Tokyo, Dec. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060074) titled 'Efficacy of contrast-enhanced harmonic EUS for gallbladder tumor' on Dec. 13.
Study Type:
Observational
Primary Sponsor:
Institute - Department of Gastroenterology, Gifu Prefectural General Medical Center
Condition:
Condition - gallbladder tumor
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the diagnostic capability in terms of differentiating malignant from benign for gallbladder tumor with contrast-enhanced EUS
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - *Long axis of lymph node <10 mm
*Pathological diagnosis obtained by surgery or EUS-FNA
Key exclusion criteria - *Cases with obvious distant metastasis or local invasion
*Blood coagulation disorder or a platelet
count of less than 50,000/uL
*Taking anticoagulant or antiplatelet drugs
*Pregnancy
*Egg allergy
*Failure of other organs
Target Size - 62
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2021 Year 03 Month 31 Day
Date of IRB - 2022 Year 04 Month 20 Day
Anticipated trial start date - 2021 Year 04 Month 01 Day
Last follow-up date - 2024 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056521
Disclaimer: Curated by HT Syndication.
